PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Jun-2023 Cyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer’s Disease Businesswire
12-Jun-2023 Element Expands Battery Testing Business in South Korea With Acquisition of NCT Businesswire
12-Jun-2023 Senda Biosciences Appoints Marc Wolfgang as Senior Vice President, Manufacturing Businesswire
12-Jun-2023 Stevanato Group Presents Vertiva™, a Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies and for Large Delivery Volumes (up to 10mL) Businesswire
12-Jun-2023 Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development Businesswire
12-Jun-2023 Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference Businesswire
12-Jun-2023 Armis Identifies Riskiest OT and ICS Devices Across Critical Infrastructure Industries Businesswire
12-Jun-2023 Enveric Biosciences to Present at H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference Businesswire
12-Jun-2023 UPLIZNA® (inebilizumab-cdon) Pivotal Trial Publication Integrating MRI and Biomarker Evaluation Shows Accuracy and Uniformity of Attack Diagnoses for Neuromyelitis Optica Spectrum Disorder (NMOSD) Businesswire
12-Jun-2023 Charles River and Curigin Collaborate to Produce Oncolytic RNAi Gene Therapy Businesswire
12-Jun-2023 Model N Named One of Fortune's 2023 Best Workplaces in the Bay Area Businesswire
12-Jun-2023 PharmaLink Announces Acquisition of PharmaReturns Newswire
12-Jun-2023 Coya Therapeutics’ CEO Dr. Howard Berman’s Letter to Stockholders Businesswire
12-Jun-2023 Simcere Pharmaceutical Group Announces Sponsored Research Agreement with Boston-based Mass General Brigham Businesswire
12-Jun-2023 Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara® Businesswire
12-Jun-2023 Catalent, Inc. Reports Third Quarter Fiscal 2023 Results Businesswire
12-Jun-2023 Merck to Present Data for Efinopegdutide (MK-6024), an Investigational GLP-1/Glucagon Receptor Co-agonist, in Patients with Nonalcoholic Fatty Liver Disease (NAFLD) at EASL 2023 Businesswire
12-Jun-2023 KalVista Pharmaceuticals Presents New Data at 2023 Meeting of the European Academy of Allergy and Clinical Immunology Businesswire
12-Jun-2023 Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use Businesswire
12-Jun-2023 Veristat Acquires European Medical Writing Consultancy Scinopsis Businesswire